TWST Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: TWST could re-rate on AI/genomics catalysts and pharma partnerships; ARK remains a buyer; near-term call volume supports upside; a Q2 beat or major deal could lift TWST to the high 60s or 70. Past bullish calls across 3–6 months realized roughly a 58% rise.




Bearish Case: Valuation remains rich; high IV; near-term catalysts could miss; macro risks and regulatory/competitive threats could anchor TWST in the mid-50s; a disappointing print or liquidity stress could trigger a sharper pullback.




Potential Outcomes:
  • Base-case (40%): TWST trades ~60–66 over 1–3 months as catalysts normalize.
  • Upside (25%): pharma/AI deals or a strong beat lift to 68–72.
  • Moderate downside (20%): no catalysts; 55–60.
  • Tail risk (15%): >10% drop on regulatory or execution shock.



May 27, 2026


Twist Bioscience Forecast

TWST        Twist Bioscience

4 Day Price Forecast + Historical Performance.  (?)

9 Day Price Forecast + Historical Performance.  (?)

20 Day Price Forecast + Historical Performance.  (?)

36 Day Price Forecast + Historical Performance.  (?)

49 Day Price Forecast + Historical Performance.  (?)

















Become a more profitable trader with AI optimized trading strategies